NEW YORK (GenomeWeb News) – Roche Diagnostics said today that it has granted a non-exclusive license of its melting curve analysis technology to Agilent Technologies
 
Under the agreement, Agilent has acquired the rights to use, develop, and sell products that are based on Roche’s melting curve analysis technique, which is used in analyzing DNA in the PCR process.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.